An evaluation of the first two years of the mandatory joint replacement episode payment program in Medicare found minor spending reductions and no effect on quality.
Read More
Research carried by Health Affairs purports to find that health care spending for certain conditions is cost-effective.
Read More
Research carried in Health Affairs looks at persistently high-cost Medicare patients.
Read More
The National Venture Capital Association gives us data on financings and exits for the fourth quarter and full year of 2018.
Read More
A study in JAMA reviews the association between cost-sharing, medication adherence and medical outcomes.
Read More
An article in Health Affairs once again tries to reinforce the point that the health spending issue in the US is due to prices, not utilization.
Read More
The Journal of the American Medical Association has a lengthy analysis of medical product marketing spending over the last two decades.
Read More
The American Hospital Association claims hospitals are grossly underpaid by Medicare and Medicaid.
Read More
The latest volley in the 340B program wars comes from the drug industry and not surprisingly finds that hospital participation raises use and spending.
Read More
JAMA carries a meta-review of interventions to improve adherence to drug regimens.
Read More
A study carried by the Journal of the American Medical Association reveals the absurd and despicable profits being earned by drug companies off the misery of cancer patients.
Read More
Among its other defects, it appears that Medicare's hospital readmissions reduction program may have led to an increase in mortality.
Read More
A Deloitte annual report looks at drug manufacturer returns on research and development activities.
Read More
A new survey from the Employee Benefits Research Institute continues to find that persons covered by high deductible plans are more engaged with their health and health care.
Read More